United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - butylscopolamine bromide (unii: 0gh9jx37c8) (butylscopolamine bromide - unii:0gh9jx37c8) -

Ireland - English - HMA (Heads of Medicines Agencies)

boehringer ingelheim b.v. - hyoscine butylbromide 20 mg/ml - solution for injection - cattle young, horses food - butylscopolamine

Italy - English - HMA (Heads of Medicines Agencies)

boehringer ingelheim b.v. - hyoscine butylbromide 20 mg/ml - solution for injection - cattle young, horses food - butylscopolamine

Netherlands - English - HMA (Heads of Medicines Agencies)

boehringer ingelheim b.v. - hyoscine butylbromide 20 mg/ml - solution for injection - cattle young, horses food - butylscopolamine

United Kingdom - English - HMA (Heads of Medicines Agencies)

boehringer ingelheim b.v. - hyoscine butylbromide 20 mg/ml - solution for injection - cattle young, horses food - butylscopolamine

United States - English - NLM (National Library of Medicine)

sj pharmaceuticals, llc - chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - chlorpheniramine maleate 4 mg in 5 ml

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - phenobarbital 16.2 mg

United States - English - NLM (National Library of Medicine)

avkare, inc - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i), scopolamine hydrobromide (unii: 451ifr0gxb) (scopolamine - unii:dl48g20x8x) - phenobarbital 16.2 mg in 5 ml - based on a review of this drug by the national academy of sciences-national research council and/or other information, fda has classified the indications as follows: "possibly" effective: for use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis. may also be useful as adjunctive therapy in the treatment of duodenal ulcer. final classification of the less-than-effective indications requires further investigation. it has not been shown conclusively whether anticholinergic/antispasmodic drugs aid in the healing of a duodenal ulcer, decrease the rate of recurrences or prevent complications. - glaucoma; - obstructive uropathy (for example, bladder neck obstruction due to prostatic hypertrophy); - obstructive disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis, etc.); - paralytic ileus, intestinal atony of the elderly or debilitated patient; - unstable cardiovascular status in acute hemorrhage; - se

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - phenobarbital 16.2 mg in 5 ml

United States - English - NLM (National Library of Medicine)

legacy pharmaceutical packaging - atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x), scopolamine hydrobromide (unii: 451ifr0gxb) (scopolamine - unii:dl48g20x8x), phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - atropine sulfate 0.0194 mg - glaucoma, obstructive uropathy (for example, bladder neck obstruction due to prostatic hypertrophy); obstructive disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis, etc.); paralytic ileus, intestinal atony of the elderly or debilitated patient; unstable cardiovascular status in acute hemorrhage; severe ulcerative colitis especially if complicated by toxic magacolon; myasthenia gravis; hiatal hernia associated with reflux esophagitis. belladonna alkaloids with phenobarbital tablets are contraindicated in patients with known hypersensitivity to any of the ingredients. phenobarbital is contraindicated in acute intermittent porphyria and in those patients in whom phenobarbital produces restlessness and/or excitement.